logo-loader
MMJ Group Holdings Ltd

MMJ PhytoTech applies for ASX re-quotation, Canadian cannabis investment enters distribution agreement

TSX Venture Exchange-listed MediPharm Labs Inc will have its medicinal and recreational products distributed by a large-scale licensed producer.

1539233491_rsz_shutterstock_283785782.jpg
MMJ is a global cannabis investment company with a portfolio of minority holdings.

MMJ PhytoTech Ltd (ASX:MMJ) has confirmed its investment MediPharm Labs Inc (TSX-V:LABS) has entered into a cannabis concentrate program agreement with Emerald Health Therapeutics Inc (TSX-V:EMH).

MMJ’s investment in MediPharm amounts to CAD$5 million, comprising 5.88 million shares at 85 Canadian cents per share and 2.94 million warrants exercisable at CAD$1.20 a share by October 2020.

 

The company has also confirmed it has made the relevant re-quotation application to the ASX after its shareholders confirmed the disposal of MMJ subsidiary PhytoTech Therapeutics Ltd on October 5 and MMJ went into suspension.

Along with approving the disposal of PhytoTech Therapeutics to Harvest One Cannabis Inc (TSX-V:HVT), MMJ shareholders voted to change the company name to MMJ Group Holdings Limited.

READ: MMJ PhytoTech invests into major Canadian medical cannabis company

The MediPharm agreement enables Emerald to provide pharmaceutical-grade cannabis concentrate products produced by MediPharm to its large base of registered patients as well as premium concentrates for adult-use recreational consumers.

MediPharm is focused on downstream secondary extraction methodology, distillation and cannabinoid isolation and purification.

The company operates of one the largest cannabis concentrate manufacturing facilities in Canada and is built current good manufacturing practices and ISO standards.

Quick facts: MMJ Group Holdings Ltd

Price: $0.25

Market: ASX
Market Cap: $56.39 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MMJ Group Holdings Ltd named herein, including the promotion by the Company of MMJ Group Holdings Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

MMJ Group focuses on strategic vision to be leading cannabis investment company

MMJ Group Holdings Ltd (ASX: MMJ) non-executive director Mike Curtis updates Proactive Investors about its strategic partnership with MMJ operating company Embark Ventures (EBV). The two companies have combined to create the highest quality investments, earnings and share price return for...

on 17/7/19

2 min read